Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty...

Published on 22 Jan 2025 on Benzinga · via Yahoo Finance

However, last year, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics deal....

Read the rest of the article

Start tracking your investments with Statfolio

Rising patient volumes, technological advancements, rate hikes and other factors are likely to ha...

Zacks · via Yahoo Finance 31 Jan 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

Investing.com 31 Jan 2025

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this articl...

Insider Monkey · via Yahoo Finance 31 Jan 2025

Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress

Investing.com 30 Jan 2025

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025

New York, NY—January 24, 2025— A research team from Columbia Engineering and the Irving Institute...

Columbia University News 24 Jan 2025

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 24 Jan 2025

According to InvestingPro data, the company maintains a "GOOD" overall financial health score,...

Investing.com 23 Jan 2025

However, last year, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics de...

Benzinga · via Yahoo Finance 22 Jan 2025

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus ...

Insider Monkey · via Yahoo Finance 20 Jan 2025